Diverse technologies have a surprising number of common threads, whether in the technologies themselves or in the clinical applications. For this reason, manufacturers need to consider that: 1. A technology platform can be the launchpad for products in clinically diverse areas. Case in point, cell therapy, which as a fundamental scientific discipline can have uses [...]
During the 19th century, surgeons began to experiment with materials designed to achieve hemostasis: gelatin, collagen, natural fabrics, and thrombin and fibrin materials. In the early 1980s today’s commercial products began to appear. They were rapidly adopted in Japan where bleeding is an extremely emotive issue, and also in Europe where local regulatory requirements allowed [...]
Taken together, the Americas represent some 60% of the global market for surgical securement (sealants, glues, hemostasis, wound closure, anti-adhesion), led by the United States with more than 50%. The relative success of each product type varies between these markets, dominated by traditional sutures and staples, but with sealants rapidly penetrating and gaining share. Source: [...]
(Continued from here) The dynamics behind these products’ success: Significant cost-effectiveness arguments can be made for products that avoid blood transfusions or reduce the quantities of blood transfusion products required. Approximately 8 million patients worldwide would benefit directly from increased usage of hemostats, sealants and glue products to reduce bleeding during cardiovascular, orthopaedic, urologic, and other [...]
There are many reasons underlying the explosive growth of the worldwide markets for surgical sealants, hemostasis, wound closure and anti-adhesion. The market potential for products in the surgical securement field is driven by a combination of new technologies coming to market and expanding caseload for which these technologies are applicable. The potential for these products [...]
The list of companies profiled in the forthcoming MedMarket Diligence report #S175 on Surgical Sealants, Glues, Wound Closure and Anti-Adhesion has been expanded based on the additional company data gathered from the worldwide analysis. The list now stands at 136 companies. See below: 4.1 3DM, Inc. (3D-Matrix, Ltd.) 4.2 3M 4.3 Abbott Vascular 4.4 AccessClosure, [...]
The companies involved in the marketing and development of surgical sealants, glues, and other wound closure and anti-adhesion products are a robust group. The number of competitors and the breadth and depth of their offerings are testimony to the size of the active market as well as its considerable potential. Below is the list of [...]
Contact:
